Insight into newly discovered innate immune modulation in atopic dermatitis

Chang Ook Park, Seongmin Noh, Shan Jin, Na Ra Lee, Yun Sun Lee, Hemin Lee, Jungsoo Lee, Kwanghoon Lee

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Atopic dermatitis (AD) is a highly pruritic, chronic relapsing inflammatory skin disease characterized by innate and adaptive immune reactions. In AD, innate immune mechanisms such as pattern recognition receptors and antimicrobial peptides have been investigated in detail, but recently, epidermis-derived cytokines, namely thymic stromal lymphopoietin (TSLP), IL-25 and IL-33, were shown to participate in innate immune reactions independently of adaptive immunity. In addition to conventional innate cells, such as mast cells, basophils and eosinophils, Th2 cytokine-producing invariant natural killer T (iNKT) cells, innate lymphoid cells (ILCs) and Th17/Th22 cytokine-producing innate cells - iNKT cells and natural killer (NK)-like cells - can participate in innate immune modulation in AD. Accordingly, early control of innate immune responses in AD before activation of adaptive immune responses by conventional T and B cells that perpetuate chronic skin inflammation may adequately alleviate acute exacerbations of AD. Therefore, we hypothesized that select immune modulators targeting the innate immune response could potentially be used for individualized treatment of AD.

Original languageEnglish
Pages (from-to)6-9
Number of pages4
JournalExperimental dermatology
Volume22
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Atopic Dermatitis
Modulation
Antigen-antibody reactions
Natural Killer T-Cells
T-cells
Adaptive Immunity
Cytokines
Innate Immunity
Skin
Pattern Recognition Receptors
Basophils
Skin Diseases
Eosinophils
Epidermis
Mast Cells
Natural Killer Cells
Modulators
B-Lymphocytes
Chemical activation
Cells

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Dermatology

Cite this

Park, Chang Ook ; Noh, Seongmin ; Jin, Shan ; Lee, Na Ra ; Lee, Yun Sun ; Lee, Hemin ; Lee, Jungsoo ; Lee, Kwanghoon. / Insight into newly discovered innate immune modulation in atopic dermatitis. In: Experimental dermatology. 2013 ; Vol. 22, No. 1. pp. 6-9.
@article{aca58fd906084a1e8e8d64527edb1dda,
title = "Insight into newly discovered innate immune modulation in atopic dermatitis",
abstract = "Atopic dermatitis (AD) is a highly pruritic, chronic relapsing inflammatory skin disease characterized by innate and adaptive immune reactions. In AD, innate immune mechanisms such as pattern recognition receptors and antimicrobial peptides have been investigated in detail, but recently, epidermis-derived cytokines, namely thymic stromal lymphopoietin (TSLP), IL-25 and IL-33, were shown to participate in innate immune reactions independently of adaptive immunity. In addition to conventional innate cells, such as mast cells, basophils and eosinophils, Th2 cytokine-producing invariant natural killer T (iNKT) cells, innate lymphoid cells (ILCs) and Th17/Th22 cytokine-producing innate cells - iNKT cells and natural killer (NK)-like cells - can participate in innate immune modulation in AD. Accordingly, early control of innate immune responses in AD before activation of adaptive immune responses by conventional T and B cells that perpetuate chronic skin inflammation may adequately alleviate acute exacerbations of AD. Therefore, we hypothesized that select immune modulators targeting the innate immune response could potentially be used for individualized treatment of AD.",
author = "Park, {Chang Ook} and Seongmin Noh and Shan Jin and Lee, {Na Ra} and Lee, {Yun Sun} and Hemin Lee and Jungsoo Lee and Kwanghoon Lee",
year = "2013",
month = "1",
day = "1",
doi = "10.1111/exd.12034",
language = "English",
volume = "22",
pages = "6--9",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "1",

}

Park, CO, Noh, S, Jin, S, Lee, NR, Lee, YS, Lee, H, Lee, J & Lee, K 2013, 'Insight into newly discovered innate immune modulation in atopic dermatitis', Experimental dermatology, vol. 22, no. 1, pp. 6-9. https://doi.org/10.1111/exd.12034

Insight into newly discovered innate immune modulation in atopic dermatitis. / Park, Chang Ook; Noh, Seongmin; Jin, Shan; Lee, Na Ra; Lee, Yun Sun; Lee, Hemin; Lee, Jungsoo; Lee, Kwanghoon.

In: Experimental dermatology, Vol. 22, No. 1, 01.01.2013, p. 6-9.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Insight into newly discovered innate immune modulation in atopic dermatitis

AU - Park, Chang Ook

AU - Noh, Seongmin

AU - Jin, Shan

AU - Lee, Na Ra

AU - Lee, Yun Sun

AU - Lee, Hemin

AU - Lee, Jungsoo

AU - Lee, Kwanghoon

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Atopic dermatitis (AD) is a highly pruritic, chronic relapsing inflammatory skin disease characterized by innate and adaptive immune reactions. In AD, innate immune mechanisms such as pattern recognition receptors and antimicrobial peptides have been investigated in detail, but recently, epidermis-derived cytokines, namely thymic stromal lymphopoietin (TSLP), IL-25 and IL-33, were shown to participate in innate immune reactions independently of adaptive immunity. In addition to conventional innate cells, such as mast cells, basophils and eosinophils, Th2 cytokine-producing invariant natural killer T (iNKT) cells, innate lymphoid cells (ILCs) and Th17/Th22 cytokine-producing innate cells - iNKT cells and natural killer (NK)-like cells - can participate in innate immune modulation in AD. Accordingly, early control of innate immune responses in AD before activation of adaptive immune responses by conventional T and B cells that perpetuate chronic skin inflammation may adequately alleviate acute exacerbations of AD. Therefore, we hypothesized that select immune modulators targeting the innate immune response could potentially be used for individualized treatment of AD.

AB - Atopic dermatitis (AD) is a highly pruritic, chronic relapsing inflammatory skin disease characterized by innate and adaptive immune reactions. In AD, innate immune mechanisms such as pattern recognition receptors and antimicrobial peptides have been investigated in detail, but recently, epidermis-derived cytokines, namely thymic stromal lymphopoietin (TSLP), IL-25 and IL-33, were shown to participate in innate immune reactions independently of adaptive immunity. In addition to conventional innate cells, such as mast cells, basophils and eosinophils, Th2 cytokine-producing invariant natural killer T (iNKT) cells, innate lymphoid cells (ILCs) and Th17/Th22 cytokine-producing innate cells - iNKT cells and natural killer (NK)-like cells - can participate in innate immune modulation in AD. Accordingly, early control of innate immune responses in AD before activation of adaptive immune responses by conventional T and B cells that perpetuate chronic skin inflammation may adequately alleviate acute exacerbations of AD. Therefore, we hypothesized that select immune modulators targeting the innate immune response could potentially be used for individualized treatment of AD.

UR - http://www.scopus.com/inward/record.url?scp=84871716468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871716468&partnerID=8YFLogxK

U2 - 10.1111/exd.12034

DO - 10.1111/exd.12034

M3 - Article

C2 - 23088736

AN - SCOPUS:84871716468

VL - 22

SP - 6

EP - 9

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

IS - 1

ER -